Simón Lykkemark

930 total citations
20 papers, 581 citations indexed

About

Simón Lykkemark is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Simón Lykkemark has authored 20 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Radiology, Nuclear Medicine and Imaging, 12 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Simón Lykkemark's work include Monoclonal and Polyclonal Antibodies Research (13 papers), Glycosylation and Glycoproteins Research (8 papers) and Advanced Biosensing Techniques and Applications (5 papers). Simón Lykkemark is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (13 papers), Glycosylation and Glycoproteins Research (8 papers) and Advanced Biosensing Techniques and Applications (5 papers). Simón Lykkemark collaborates with scholars based in Denmark, Spain and China. Simón Lykkemark's co-authors include Luis Álvarez‐Vallina, Jianhua Qin, Laura Sanz, Marta Compte, Jingyun Ma, Yue Yu, Hui Wen, Hui Xu, Peter Kristensen and Seandean L. Harwood and has published in prestigious journals such as Nucleic Acids Research, Advanced Materials and PLoS ONE.

In The Last Decade

Simón Lykkemark

20 papers receiving 567 citations

Peers

Simón Lykkemark
Hsuan‐Chen Liu United States
Ricardo M. Gouveia United Kingdom
Sahar Awwad United Kingdom
Dong Hyun Nam South Korea
Joshua A. Gustafson United States
Sachin Bhagchandani United States
Simón Lykkemark
Citations per year, relative to Simón Lykkemark Simón Lykkemark (= 1×) peers Siyuan Chen

Countries citing papers authored by Simón Lykkemark

Since Specialization
Citations

This map shows the geographic impact of Simón Lykkemark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simón Lykkemark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simón Lykkemark more than expected).

Fields of papers citing papers by Simón Lykkemark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simón Lykkemark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simón Lykkemark. The network helps show where Simón Lykkemark may publish in the future.

Co-authorship network of co-authors of Simón Lykkemark

This figure shows the co-authorship network connecting the top 25 collaborators of Simón Lykkemark. A scholar is included among the top collaborators of Simón Lykkemark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simón Lykkemark. Simón Lykkemark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lykkemark, Simón, et al.. (2021). Programmable half-life and anti-tumour effects of bispecific T-cell engager-albumin fusions with tuned FcRn affinity. Communications Biology. 4(1). 310–310. 43 indexed citations
2.
Just, Jesper, Mogens Kruhøffer, Simón Lykkemark, et al.. (2019). Human Mast Cell Sensitization with IgE Increases miRNA-210 Expression. International Archives of Allergy and Immunology. 179(2). 102–107. 9 indexed citations
3.
Mikkelsen, Kasper, Seandean L. Harwood, Marta Compte, et al.. (2019). Carcinoembryonic Antigen (CEA)-Specific 4-1BB-Costimulation Induced by CEA-Targeted 4-1BB-Agonistic Trimerbodies. Frontiers in Immunology. 10. 1791–1791. 16 indexed citations
4.
Blanco, Belén, Marta Compte, Simón Lykkemark, Laura Sanz, & Luis Álvarez‐Vallina. (2019). T Cell-Redirecting Strategies to ‘STAb’ Tumors: Beyond CARs and Bispecific Antibodies. Trends in Immunology. 40(3). 243–257. 34 indexed citations
5.
Lykkemark, Simón, et al.. (2017). Targeting of phage particles towards endothelial cells by antibodies selected through a multi-parameter selection strategy. Scientific Reports. 7(1). 42230–42230. 8 indexed citations
6.
Lykkemark, Simón, et al.. (2017). A novel excision selection method for isolation of antibodies binding antigens expressed specifically by rare cells in tissue sections. Nucleic Acids Research. 45(11). e107–e107. 5 indexed citations
7.
Just, Jesper, Simón Lykkemark, Kim Ryun Drasbek, et al.. (2017). Pericyte modulation by a functional antibody obtained by a novel single‐cell selection strategy. Microcirculation. 24(6). 3 indexed citations
8.
Harwood, Seandean L., Ana Álvarez‐Cienfuegos, Natalia Nuñez‐Prado, et al.. (2017). ATTACK, a novel bispecific T cell-recruiting antibody with trivalent EGFR binding and monovalent CD3 binding for cancer immunotherapy. OncoImmunology. 7(1). e1377874–e1377874. 64 indexed citations
9.
Fridriksdottir, Agla J., et al.. (2016). Raising an Antibody Specific to Breast Cancer Subpopulations Using Phage Display on Tissue Sections.. PubMed. 13(1). 21–30. 8 indexed citations
10.
Sánchez‐Martín, David, Simón Lykkemark, Laura Sanz, et al.. (2015). Selection strategies for anticancer antibody discovery: searching off the beaten path. Trends in biotechnology. 33(5). 292–301. 23 indexed citations
11.
Fridriksdottir, Agla J., et al.. (2015). Selection of a breast cancer subpopulation-specific antibody using phage display on tissue sections. Immunologic Research. 62(3). 263–272. 10 indexed citations
12.
Just, Jesper, Tobias Jung, Simón Lykkemark, et al.. (2015). Identification of an unstable 4-hydroxynoneal modification on the 20S proteasome subunit α7 by recombinant antibody technology.. Free Radical Biology and Medicine. 89. 786–792. 14 indexed citations
13.
Nuñez‐Prado, Natalia, Marta Compte, Seandean L. Harwood, et al.. (2015). The coming of age of engineered multivalent antibodies. Drug Discovery Today. 20(5). 588–594. 100 indexed citations
14.
Meng, Zhaoxu, et al.. (2015). Flexible Fabrication of Shape‐Controlled Collagen Building Blocks for Self‐Assembly of 3D Microtissues. Small. 11(30). 3666–3675. 27 indexed citations
15.
Lykkemark, Simón, et al.. (2015). Selection of cell‐type specific antibodies on tissue‐sections using phage display. Journal of Cellular and Molecular Medicine. 19(8). 1939–1948. 11 indexed citations
16.
Zhang, Xu, Zhaoxu Meng, Jingyun Ma, et al.. (2015). Microdevices: Flexible Fabrication of Shape‐Controlled Collagen Building Blocks for Self‐Assembly of 3D Microtissues (Small 30/2015). Small. 11(30). 3665–3665. 2 indexed citations
17.
Lykkemark, Simón, et al.. (2014). Degradation of C-terminal tag sequences on domain antibodies purified fromE. colisupernatant. mAbs. 6(6). 1551–1559. 11 indexed citations
18.
Yu, Yue, Hui Wen, Jingyun Ma, et al.. (2014). Biomimetics: Flexible Fabrication of Biomimetic Bamboo‐Like Hybrid Microfibers (Adv. Mater. 16/2014). Advanced Materials. 26(16). 2449–2449. 2 indexed citations
19.
Yu, Yue, Hui Wen, Jingyun Ma, et al.. (2014). Flexible Fabrication of Biomimetic Bamboo‐Like Hybrid Microfibers. Advanced Materials. 26(16). 2494–2499. 152 indexed citations
20.
Lykkemark, Simón, et al.. (2013). A Novel Heavy Domain Antibody Library with Functionally Optimized Complementarity Determining Regions. PLoS ONE. 8(10). e76834–e76834. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026